Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian Cancer

Clinical trial NCT02788708 · COMPLETED

Trial details

NCT number: NCT02788708
Sponsor: Floor Backes
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Fallopian Tube Carcinoma Recurrent Ovarian Cancer Primary Peritoneal Carcinoma Recurrent Endometrial Cancer

Start date: 2016-05-27
Primary completion: 2021-12-31
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.